EUROSCREEN RECEIVES KEY PATENT FOR PURINERGIC RECEPTOR

Euroscreen SA May 26 announced that it was awarded a US patent that covers the use of a G-protein-coupled receptor (GPCR) known as the human P2Y11 receptor. Euroscreen's patent protects the sequence of P2Y11 receptor and research tools comprising this sequence.

PR Web (http://www.prweb.com/releases/2006/5/prweb384934.htm)